Percevia Logo
In Vitro Analysis

In Vitro Depigmentation & Skin Lightening Analysis

RHPE — Reconstructed Human Pigmented Epidermis

Evaluate the efficacy of depigmenting and whitening active ingredients using validated 3D human pigmented skin models. Quantitative, reproducible results that support cosmetic claims and accelerate your product development.

RHPE
II

Phototype II

IV

Phototype IV

VI

Phototype VI

The RHPE Skin Model

The Reconstructed Human Pigmented Epidermis (RHPE) is a 3D tissue model cultivated at the air-liquid interface in chemically defined medium. Normal human keratinocytes are cultured in the presence of melanocytes, forming fully differentiated epidermal tissue that faithfully reproduces the pigmentation characteristics of human skin.

3D co-culture of keratinocytes and melanocytes at the air-liquid interface

Available in 3 phototypes (II, IV, VI) representing different skin tones

Chemically defined medium — no animal-derived components

Fully differentiated epidermis with functional melanin units

Validated for depigmentation and pigmentation modulation assays

Quantitative endpoints: colorimetry (CIELab), UV-Vis reflectance, melanin extraction

Download the EPISKIN RHPE Data Sheet

Download PDF

Available Phototypes

II

Phototype II

Light skin — ideal for evaluating skin brightening in fair complexions

IV

Phototype IV

Medium skin — the most versatile model for general depigmentation studies

VI

Phototype VI

Dark skin — suited for evaluating strong whitening agents and ethnic-specific formulations

Depigmentation Analysis Services

Six specialized services for comprehensive evaluation of depigmenting and skin lightening active ingredients using the RHPE model.

COS-101

Skin Lightening Assessment

Quantitative evaluation of depigmenting effect by instrumental colorimetry (CIELab). Measures L* (lightness), a* (red-green), b* (yellow-blue) and ITA° (Individual Typology Angle) parameters under D65 illuminant.

Technique

Colorimetry (CIELab / ITA°)

Endpoints

  • L* (lightness)
  • a* (red-green axis)
  • b* (yellow-blue axis)
  • ITA° (Individual Typology Angle)

Claims Supported

Skin brightening
Complexion uniformity
Dark spot reduction
COS-102

Melanin Index Quantification

Non-destructive quantification of melanin content by UV-Vis reflectance spectrophotometry in the 400–800 nm range. Provides Melanin Index (MI) for objective comparison between treated and control tissues.

Technique

UV-Vis Reflectance Spectrophotometry (400–800 nm)

Endpoints

  • Melanin Index (MI)
  • Reflectance spectra (400–800 nm)

Claims Supported

Melanin reduction
Pigmentation control
Whitening efficacy
COS-103

Absolute Melanin Quantification

Destructive extraction of total melanin from the epidermal tissue followed by spectrophotometric dosage. Quantifies absolute melanin content (µg/tissue) for definitive efficacy assessment.

Technique

Melanin Extraction + Spectrophotometric Dosage

Endpoints

  • Total melanin content (µg/tissue)
  • Melanin reduction (%)

Claims Supported

Proven melanin reduction
Quantified depigmentation
COS-104

Dose-Response Depigmenting Efficacy

Evaluation of the product at 3 concentrations to establish a dose-response relationship. Determines optimal concentration and therapeutic window for the depigmenting active ingredient.

Technique

Multi-concentration colorimetric analysis

Endpoints

  • Dose-response curve
  • EC50 estimation
  • Optimal concentration range

Claims Supported

Clinically optimized concentration
Dose-dependent efficacy
COS-105

Mechanism-Specific Depigmentation Study

Investigation of the depigmentation mechanism by tyrosinase activity assay (DOPA oxidation) combined with histological analysis of melanosome distribution (Fontana-Masson staining). Differentiates between tyrosinase inhibition and melanosome transfer disruption.

Technique

Tyrosinase assay (DOPA) + Fontana-Masson histology

Endpoints

  • Tyrosinase activity (%)
  • Melanosome distribution score
  • Mechanism classification

Claims Supported

Tyrosinase inhibitor
Melanosome transfer blocker
Targeted mechanism of action
Complete
COS-106

Complete In Vitro Depigmentation Study

Comprehensive package combining all analytical endpoints: CIELab colorimetry, UV-Vis melanin index, absolute melanin quantification, dose-response at 3 concentrations, and mechanism of action study. Provides a complete scientific dossier for regulatory submission and marketing claims.

Technique

Combined multi-technique protocol

Endpoints

  • All endpoints from COS-101 to COS-105
  • Integrated scientific report
  • Statistical analysis (ANOVA)

Claims Supported

Complete efficacy dossier
Multi-parameter validation
Regulatory-grade evidence

Technical Specifications

Ready to Evaluate Your Depigmenting Active?

Our team of experts will design a customized in vitro study using the RHPE model to generate the scientific evidence your product needs. From single-endpoint screening to comprehensive efficacy dossiers.